Major and minor risk factors for cardiovascular disease in continuous ambulatory peritoneal dialysis patients

被引：0
作者：
Prichard, S [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Dept Med, Div Nephrol,Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
来源：
PERITONEAL DIALYSIS INTERNATIONAL | 1999年 / 19卷
关键词：
atherosclerosis risk; dyslipidemia;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S133 / S137
页数：5
相关论文
共 53 条
[1]  
BACHMANN J, 1995, J AM SOC NEPHROL, V6, P121
[2]  
Becker BN, 1997, J AM SOC NEPHROL, V8, P475
[3]  
Blake PG, 1997, PERITON DIALYSIS INT, V17, P317
[4]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[5]  
BLOEMBERGEN WE, 1995, J AM SOC NEPHROL, V6, P184
[6]  
BLOEMBERGEN WE, 1995, J AM SOC NEPHROL, V6, P177
[7]   High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients [J].
Bostom, AG ;
Shemin, D ;
Lapane, KL ;
Hume, AL ;
Yoburn, D ;
Nadeau, MR ;
Bendich, A ;
Selhub, J ;
Rosenberg, IH .
KIDNEY INTERNATIONAL, 1996, 49 (01) :147-152
[8]   Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes [J].
Bostom, AG ;
Lathrop, L .
KIDNEY INTERNATIONAL, 1997, 52 (01) :10-20
[9]  
Breborowicz A, 1997, PERITON DIALYSIS INT, V17, pS37
[10]   CANADIAN HEMODIALYSIS MORBIDITY STUDY [J].
CHURCHILL, DN ;
TAYLOR, DW ;
COOK, RJ ;
LAPLANTE, P ;
BARRE, P ;
CARTIER, P ;
FAY, WP ;
GOLDSTEIN, MB ;
JINDAL, K ;
MANDIN, H ;
MCKENZIE, JK ;
MUIRHEAD, N ;
PARFREY, PS ;
POSEN, GA ;
SLAUGHTER, D ;
ULAN, RA ;
WERB, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) :214-234
123456